Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2019 Earnings and Company Update

CAMBRIDGE, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present first quarter 2019 results and operational highlights in a conference call on May 2, 2019 at 8 a.m. ET.

The investor presentation may be downloaded starting at 7:30 a.m. ET from the Events and Presentations page of the Investor Relations section of Intellia’s website at intelliatx.com.

U.S. callers should dial 800-458-4148 and use conference ID# 7725705, approximately five minutes before the call.

International callers should click here to access dial-in information and use conference ID# 7725705, approximately five minutes before the call.

A replay of the call will be available on Intellia’s website, beginning on May 2, 2019 at 12 p.m. ET.

About Intellia Therapeutics

Senior Manager, Investor Relations

Jennifer Mound Smoter

Senior Vice President, External Affairs & Communications